>Based on the above, considering the similar responses [of Baraclude and Tyzeka] to Lamivudine, you'd need to run a very large head to head trial to see any distinction at one year.<
A non-inferiority trial would work
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”